Patterson Companies, Inc. (NASDAQ: PDCO), a
distributor of consumable dental products and other services, is expected to see pressure in the coming years to its growth profile
and market share take, according to analysts at Stifel.
Stifel's Jonathan Block downgrades Patterson's stock rating from Hold to Sell with a newly established $39 price target,
mostly due to expected pressure on its equipment results. Specifically, Henry Schein, Inc. (NASDAQ: HSIC) will begin distributing DENTSPLY SIRONA Inc (NASDAQ: XRAY)'s full line of dental equipment in North America as of Sept. 1.
Pro's Perspective
A survey was conducted among industry professionals who considered Henry Schein as their primary distributor and was asked if
their respective practice is more likely to purchase high-tech equipment from Dentsply Sirona.
The analyst believes that if Patterson was previously selling approximately 1,000 CEREC units in North America then Henry Schein's
increased presence in the space could help accelerate market adoption, but naturally at the expense of Patterson (see Block's track
record here). As a result, 1,100 units could be sold, but only 800
to 900 comes from Patterson with the remaining 200 to 300 units from Henry Schein, the analyst noted. However, Patterson's bigger
problem could be the impact to its consumable market share.
"Our prior work highlighted Patterson's dominant consumable market share within CEREC accounts, and today's work suggests share
losses may take place among a subset of these accounts once Henry Schein starts
supporting the Dentsply Sirona product line," the analyst explained.
In terms of numbers, Patterson's consumable share within CEREC practices could fall from 59.9 percent to 53.5 percent, Block
added. Working under the assumption that CEREC accounts for half of Patterson's dental consumable revenue, it is possible the
company's North American consumable share could drop by at least 200 basis points over the next two years.
At last check, shares of Patterson were down 6.41 percent at $44.39.
Related Links:
Mid-Day Market
Update: Crude Oil Up Over 2%; Egalet Shares Plummet
Analysts
Give 3 Medtech Stocks A Health Screening
________
Image Credit: [Public domain], via Wikimedia
Commons
Latest Ratings for PDCO
Date |
Firm |
Action |
From |
To |
Jul 2017 |
Stifel Nicolaus |
Downgrades |
Hold |
Sell |
Apr 2017 |
Craig-Hallum |
Initiates Coverage On |
|
Hold |
Mar 2017 |
Deutsche Bank |
Initiates Coverage On |
|
Hold |
View More Analyst Ratings for
PDCO
View the Latest Analyst Ratings
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.